Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Tasly Pharmaceutical Group Co., Ltd

Market Cap 21.05B 3.11B 2.71B 2.51B 2.35B 4.41B 293B 4.44B 29.79B 11.55B 144B 11.67B 11.42B 502B P/E 2026 *
15.8x
P/E 2027 * 13.3x
Enterprise Value 18.79B 2.78B 2.42B 2.24B 2.1B 3.94B 262B 3.96B 26.6B 10.31B 129B 10.42B 10.2B 448B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.87x
Free-Float
46.34%
Yield 2026 *
2.85%
Yield 2027 * 3.57%
1 day-0.07%
1 week-2.22%
Current month+0.14%
1 month-2.36%
3 months-0.07%
6 months-7.49%
Current year-6.50%
1 week 13.97
Extreme 13.97
14.6
1 month 13.73
Extreme 13.73
14.6
Current year 13.45
Extreme 13.45
15.49
1 year 13.45
Extreme 13.45
17.69
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 2024-05-07
Director of Finance/CFO 49 2018-07-08
Chief Investment Officer 45 2025-04-30
Director TitleAgeSince
Director/Board Member 62 2007-08-16
Director/Board Member 72 2021-06-01
Director/Board Member 54 2006-03-24
Change 5-day change 1-year change 3-year change Capi.($)
-0.07%-2.22%-8.68%-2.22% 3.11B
-0.98%-4.29%-11.99%-8.50% 12.77B
-1.84%-5.81%-34.45%-58.68% 4.76B
-3.47%-9.51%-12.31%-7.72% 4.34B
+0.29%-1.20%+15.26%-17.47% 3.8B
+0.47%-4.39%+7.90%-43.34% 3.71B
-1.30%-4.43%-5.64%-10.07% 3.53B
-0.71%+0.39%-3.90%-25.43% 2.38B
-1.61%-3.41%-15.43%+28.56% 1.67B
-0.96%-4.29%-10.74%-16.55% 1.64B
Average -1.02%-3.92%-8.00%-16.14% 4.17B
Weighted average by Cap. -1.06%-4.29%-9.18%-17.52%

Financials

2026 *2027 *
Net sales 9B 1.33B 1.16B 1.07B 1B 1.88B 125B 1.9B 12.73B 4.93B 61.72B 4.99B 4.88B 214B 9.87B 1.46B 1.27B 1.18B 1.1B 2.07B 138B 2.08B 13.97B 5.41B 67.72B 5.47B 5.36B 235B
Net income 1.33B 196M 171M 158M 148M 278M 18.5B 280M 1.88B 728M 9.1B 736M 720M 31.61B 1.59B 234M 204M 189M 177M 332M 22.11B 334M 2.24B 870M 10.88B 880M 861M 37.79B
Net Debt -2.26B -334M -291M -269M -252M -473M -31.47B -476M -3.2B -1.24B -15.49B -1.25B -1.23B -53.79B -2.58B -380M -332M -307M -288M -539M -35.9B -543M -3.64B -1.41B -17.67B -1.43B -1.4B -61.35B
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
26-06-18 14.09 ¥ -0.07% 6,295,319
26-06-17 14.10 ¥ -0.77% 5,621,452
26-06-16 14.21 ¥ -2.20% 7,621,471
26-06-15 14.53 ¥ +0.83% 11,681,030
26-06-12 14.41 ¥ +1.48% 12,551,480
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.09CNY
Average target price
17.18CNY
Spread / Average Target
+21.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!